Discovery of LC-MI-3: A Potent and Orally Bioavailable Degrader of Interleukin-1 Receptor-Associated Kinase 4 for the Treatment of Inflammatory DiseasesLingfeng Chen, Guang Liang, Shiyan Chen et al.|Journal of Medicinal Chemistry|2024Cited by 6